Updated time: 2021-11-08 14:30:25
12A-1060110
TW I659750、US 11135164 B2
The invention describes an intracardiac drug delivery system, capable of capturing and retaining selected protective and/or regenerative drugs at a specified site. These drugs may be given intravenously, and will circulate to the capture site, bind the antibody, and therefore be retained. This accumulated retention allows the drugs to reach a therapeutic concentration over time. The system is “reloadable” in that subsequent intravenous injections can be administered which will increase the intracardiac concentration of the drug.
- Increases drug concentration delivered to the heart after systemic injection
- Enables lower systemic doses to be used – less side effects
- Only requires one intracardiac injection but allows multiple protective and/or regenerative drug deliveries
- Therapy of myocardial infarction
- Therapy of other cardiomyopathies
Patrick CH Hsieh, David J. Lundy, Christopher Yu Tai Yen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Optimization of reloadable hydrogel system for treating myocardial infarction